ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.

Raghvendra M Srivastava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.